Drug Profile
Recombinant human thrombopoietin - Biolotus
Alternative Names: rhTPO - Biolotus; TPO - Biolotus; ZYPOTIN-TPOLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biolotus
- Class Antianaemics; Colony-stimulating factors; Glycoproteins; Hepatoprotectants
- Mechanism of Action Thrombopoietin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Thrombocytopenia
Most Recent Events
- 18 Jun 2015 Launched for Thrombocytopenia in Brazil (SC) before June 2015